EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic Diversity and Antiretroviral Resistance in HIV-1-Infected Patients Newly Diagnosed in Cabo Verde

Silvânia Da Veiga Leal iD, Victor Pimentel iD, Paloma Gonçalves iD, Isabel Inês Monteiro de Pina Araújo iD, Ricardo Parreira iD, Nuno Taveira iD, Marta Pingarilho iD, Ana B Abecasis iD

Viruses · 20.12.2024 · 16 (12) · 1953

DOI: 10.3390/v16121953 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, online erschienen am 20.12.2024. Verfasst von Silvânia Da Veiga Leal und 7 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Nacional de Saúde Pública de Cabo Verde, Largo do Desastre da Assistência, Chã de Areia, Praia CP 7943-010, Cape Verde. Hauptthemen laut MEDLINE: HIV-1, HIV Infections, Drug Resistance, Viral, Genetic Variation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, Integriv, MigrantHIV - PTDC/DTP-EPI/7066/2014 and GHTM - FCT GHTM.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The high genetic variability of HIV-1 and the emergence of transmitted drug resistance (TDR) can impact treatment efficacy. In this study, we investigated the prevalent HIV-1 genotypes and drug-resistance-associated mutations in drug-naïve HIV-1 individuals in Cabo Verde. The study, conducted between 2018 and 2019, included drug-naïve HIV-1 individuals from the São Vicente, Boa Vista, Fogo, and Santiago islands. The HIV-1 pol gene was sequenced using Sanger sequencing. TDR was identified using the Stanford Calibrated Population Resistance tool, and resistance levels to different drugs were interpreted with the Stanford HIV database. The genetic diversity of HIV-1 was determined through phylogenetic analysis, and epidemiological and behavioural data were collected via questionnaires. Of the 73 participants, the majority were male (52.1%). The CRF02_AG recombinant form predominated (41.1%), followed by subtype G (37.0%). The overall prevalence of TDR was 9.6%. Nucleoside Reverse Transcriptase Inhibitor (NRTI) mutations occurred in 2.7% of individuals, while Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) mutations occurred in 9.6%. The most prevalent mutations were K103N (5.5%) and M184V (2.7%). No protease- or integrase-associated mutations were found. The high levels of resistance to NNRTIs found demonstrate the need for surveillance of resistance mutations to ensure the efficacy and durability of the current therapeutic regimen, which includes Dolutegravir.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1HIV InfectionsDrug Resistance, ViralGenetic VariationPhylogenyGenotypeMutationAnti-HIV AgentsHumansMaleFemaleAdultMiddle AgedCabo VerdeYoung AdultPrevalence

Stichwörter der Autor:innen

Cabo VerdeHIV-1 subtypesgenetic diversitygenomic surveillancetransmitted drug resistance

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Instituto Nacional de Saúde Pública de Cabo Verde, Largo do Desastre da Assistência, Chã de Areia, Praia CP 7943-010, Cape Verde.
  • Global Health and Tropical Medicine, GHTM, Associate Laboratory in Translation and Innovation Towards Global Health, LA-REAL, Instituto de Higiene e Medicina Tropical, IHMT, Universidade NOVA de Lisboa, Rua da Junqueira…
  • Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Avenida Professor Gama Pinto, 1649-003 Lisboa, Portugal.
  • Faculdade de Ciências e Tecnologia, Universidade de Cabo Verde, Campus do Palmarejo Grande, Praia CP 7943-010, Cape Verde.
  • One Health Research Center-Cabo Verde (NEST-CV), Universidade de Cabo Verde, Campus do Palmarejo Grande, Praia CP 7943-010, Cape Verde.
  • Centro de Investigação Interdisciplinar Egas Moniz (CiiEM), Egas Moniz School of Health & Science, Quinta da Granja, Monte de Caparica, 2829-511 Almada, Portugal.

ORCID-Profile: Silvânia Da Veiga Leal, Victor Pimentel, Paloma Gonçalves, Isabel Inês Monteiro de Pina Araújo, Ricardo Parreira, Nuno Taveira, Marta Pingarilho, Ana B Abecasis

Förderung

  • Fundação para a Ciência e Tecnologia
  • Integriv
  • MigrantHIV - PTDC/DTP-EPI/7066/2014 and GHTM - FCT GHTM
  • Fundação para a Ciência e Tecnologia (FCT) and Aga Khan Development Network (AKDN)
  • Millennium BCP Foundation
  • Camões I.P.
  • Aga Khan Development Network (AKDN)

Zitieren

APA

Leal, S. D. V., Pimentel, V., Gonçalves, P., Monteiro de Pina Araújo, I. I., Parreira, R., Taveira, N., Pingarilho, M., & Abecasis, A. B. (2024). Genetic Diversity and Antiretroviral Resistance in HIV-1-Infected Patients Newly Diagnosed in Cabo Verde. Viruses, 16(12), 1953. https://doi.org/10.3390/v16121953

Vancouver

Leal SDV, Pimentel V, Gonçalves P, Monteiro de Pina Araújo II, Parreira R, Taveira N, et al. Genetic Diversity and Antiretroviral Resistance in HIV-1-Infected Patients Newly Diagnosed in Cabo Verde. Viruses. 2024;16(12):1953. doi:10.3390/v16121953

BibTeX
@article{Leal2024,
  author = {Leal, Silvânia Da Veiga and Pimentel, Victor and Gonçalves, Paloma and Monteiro de Pina Araújo, Isabel Inês and Parreira, Ricardo and Taveira, Nuno and Pingarilho, Marta and Abecasis, Ana B},
  title = {Genetic Diversity and Antiretroviral Resistance in HIV-1-Infected Patients Newly Diagnosed in Cabo Verde},
  journal = {Viruses},
  year = {2024},
  volume = {16},
  number = {12},
  pages = {1953},
  doi = {10.3390/v16121953}
}
Kostenlos starten →